MFDS
- Status: likely_approved
🇰🇷 Icosapent in South Korea
Icosapent (Eicosapentaenoic acid) regulatory status in South Korea.
Marketing authorisation
Icosapent in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in South Korea
Frequently asked questions
Is Icosapent approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Icosapent in South Korea?
National Institute on Alcohol Abuse and Alcoholism (NIAAA) is the originator. The local marketing authorisation holder may differ — check the official source linked above.